Kerstin Noelle Vokinger: New cancer therapies are being approved for patient groups not included in clinical trials'
Briefly

The fight against cancer involves both impressive advancements, like CAR-T therapies, yet less than half of new treatments actually enhance survival rates, highlighting a significant gap.
Kerstin Noelle Vokinger's investigation is pivotal as it examines the mismatch between clinical trial participants and actual patients, a crucial factor influencing treatment outcomes.
Read at english.elpais.com
[
|
]